Atgam

Atgam (Anti-T Lymphocyte Immunoglobulin) is an immunosuppressive medication used to prevent organ rejection. This horse-derived immunoglobulin is administered intravenously for therapeutic purposes.

Atgam is primarily used to suppress the immune system in patients undergoing organ transplants. It helps prevent the body from rejecting the transplanted organ by targeting T lymphocytes. This medication is often considered when other immunosuppressive treatments are ineffective or unsuitable.

Common effects of Atgam may include fever, chills, and allergic reactions. Some patients might experience nausea, vomiting, or changes in blood pressure. These effects can vary depending on individual tolerance and dosage.

Atgam should be administered under medical supervision due to its potent immunosuppressive properties. Patients with a history of severe allergic reactions to horse proteins should exercise caution. Regular monitoring is essential to manage potential side effects effectively.

Atgam may interact with other immunosuppressive drugs, increasing the risk of infections. It is important to inform healthcare providers about all medications being taken to avoid adverse interactions. Alcohol and certain over-the-counter drugs might also affect its efficacy.